Immunogenetics of hepatitis B virus infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue SUPPL. 3, 2002, Pages

  Han, Kwang Hyub ^a   Kim, Kyun Hwan ^a   Chang, Hye Young ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEPATITIS B ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; MANNOSE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

CELLULAR IMMUNITY; CONFERENCE PAPER; DNA POLYMORPHISM; HEPATITIS B; HEPATITIS B VIRUS; HISTOCOMPATIBILITY COMPLEX; HUMAN; IMMUNOGENETICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION;

EID: 0036456870     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.17.s3.22.x     Document Type: Conference Paper

References (17)

1. Karyiannis P, Alexopoulou A, Hadziyannis SJ et al. Fulminant hepatitis associated with hepatitis B e antigen negative infection: Importance of host factors. Hepatology 1995; 22: 1628-34.
2. Lin TM, Chen CJ, Wu MM et al. Hepatitis B virus markers in Chinese twins. Anticancer Res. 1989; 9: 737-42.
3. Hill AV. The immunogenetics of human infectious diseases. Annu. Rev. Immunol. 1998; 16: 593-617.
4. Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis and the human genome. Hepatology 2000; 31: 819-27.
5. Thursz MR. Host genetic factors influencing the outcome of hepatitis. J. Viral Hepatol. 1997; 4: 215-20.
6. Ahn SH, Han KH, Park JY et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000; 31: 1371-3.
7. Thomas HC, Thursz MR. Immunogenetics of hepatitis B virus infection. J. Viral Hepatol. 1997; 4: 98-100.
8. Thursz MR, Kwiatkowski D, Allsopp CEM et al. Assoication between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 1995; 332: 1065-9.
9. Hohler T, Gerken G, Notghi Aet al. HLA-DRB1*1302 and d*1302 protect against chronic hepatitis B. J. Heptol. 1997; 26: 503-7.
10. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNF alpha promoter region. Immunogenetics 1994; 39: 150-4.
11. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J. Exp. Med. 1993; 177: 557-60.
12. Wilson AG, Symon JA, McDowell TL et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. 1997; 94: 3195-9.
13. Hohler T, Kruger A, Gerken Pet al. A tumor necrosis factor-alpha promoter polymorphism is associated with chronic hepatitis B infection. Clin. Exp. Immunol. 1998; 111: 579-82.
14. Thomas HC, Foster GR, Sumiya M et al. Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 1996; 348: 1417-19.
15. Yuen MF, Lau CS, Lau YL, Wong WM, Cheng CC, Lai CL. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology 1999; 29: 1248-51.
16. Bellamy R, Ruwende C, Corrah Tet al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis. 1999; 179: 721-4.
17. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36.